OHSU Knight Cancer Institute: all 243 studies

Page 2 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• Daptomycin in Treating Neutropenia and Fever in Patients With CancerCompletedNCT00335478Phase 2Results posted
• Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00331409Phase 2Results posted
• Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate CancerTerminatedNCT00321698Phase 1/2Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerTerminatedNCT00258440Not applicableResults posted
• Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate CancerCompletedNCT00253643Not applicableResults posted
• Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00253513Phase 1/2Results posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantCompletedNCT00248547Not applicableResults posted
• Imatinib Mesylate in Treating Patients With MyelofibrosisTerminatedNCT00245128Phase 2Results posted
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00245037Phase 1/2Results posted
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaCompletedNCT00238433Phase 2Results posted
• Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune SystemsTerminatedNCT00238355Phase 2Results posted
• Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For CancerTerminatedNCT00217724Not applicableResults posted
• Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral MetastasesCompletedNCT00103038Not applicableResults posted
• Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment RegimenTerminatedNCT00074165Phase 2Results posted
• Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00022490Phase 2Results posted
• Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00017563Phase 2Results posted
• Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00015847Phase 2Results posted
• Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN TrialSuspendedNCT06673095Not applicable
• Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate CancerWithdrawnNCT06528210Phase 2
• Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal AdenocarcinomaWithdrawnNCT06398587Phase 2
• BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an EndoscopyActive, not recruitingNCT06335966
• Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA MelanomaActive, not recruitingNCT06157099Phase 2
• An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer SurgeryCompletedNCT06079697Not applicable
• Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With GliomasCompletedNCT05937776
• Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial TumorsWithdrawnNCT05904704Not applicable
• Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related SymptomsCompletedNCT05793957Not applicable
• Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )CompletedNCT05790538
• Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETActive, not recruitingNCT05722925Phase 4
• Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual TraumaCompletedNCT05458869
• The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients with Head and Neck Cancer Undergoing Radiation TherapyTerminatedNCT05457478Not applicable
• Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation ToolActive, not recruitingNCT05407168Not applicable
• Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid LeukemiaActive, not recruitingNCT05396859Phase 1
• ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian CancerWithdrawnNCT05368506Early Phase 1
• Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the ProstateSuspendedNCT05362032Not applicable
• Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular CarcinomaWithdrawnNCT05327738Phase 2
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• Y-90 Versus SBRT for Inoperable HCCWithdrawnNCT05157451Phase 2
• Pain Management for Head and Neck Cancer SurvivorsCompletedNCT05115825Not applicable
• Telehealth & HPV Self-CollectionCompletedNCT05089825Not applicable
• StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer PatientsWithdrawnNCT05073172Not applicable
• Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic CancerCompletedNCT05034627Phase 1
• Effects of Simulated Solar Radiation on Human Skin in Preventing Skin CancerCompletedNCT05027009Not applicable
• Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerCompletedNCT05012813Not applicable
• Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyActive, not recruitingNCT04993313Not applicable
• Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung CancerActive, not recruitingNCT04946279Not applicable
• Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute LeukemiaActive, not recruitingNCT04872790Phase 1
• Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT04850599Phase 2
• A Digital Intervention Protocol to Enhance Recovery After Head and Neck SurgeryCompletedNCT04814524Not applicable
• Virtual Reality Experiences for Anxiety and Pain ControlCompletedNCT04759183Not applicable
• War on Melanoma™ Public Health & Education CampaignActive, not recruitingNCT04611568Not applicable
• Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast CancerCompletedNCT04481113Phase 1
• Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last YearWithdrawnNCT04455958Phase 2
• Monitoring Heart Rate Variability for the Early Detection of Pancreatic CancerTerminatedNCT04400903
• Virtual Reality for the Education of Cancer Patients Undergoing Radiation TherapyTerminatedNCT04278534Not applicable
• Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerActive, not recruitingNCT04267887Phase 2
• Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk PatientsCompletedNCT04172493Not applicable
• Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral NeuropathyCompletedNCT04170075Not applicable
• TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal CancerCompletedNCT04104139Phase 1
• Glucarpidase After High-Dose Methotrexate in Patients With OsteosarcomaCompletedNCT03960177Early Phase 1
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for MelanomaTerminatedNCT03699995Not applicable
• Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation TherapyCompletedNCT03677531Phase 1
• Exercise Program Among Lung Cancer DyadsCompletedNCT03649737Not applicable
• Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue SarcomaWithdrawnNCT03613259Early Phase 1
• Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast CancerCompletedNCT03544125Phase 1
• Exercising Together During Radiation TreatmentCompletedNCT03418025Not applicable
• Internet-Based Exercise and Diet Support in Prostate Cancer SurvivorsCompletedNCT03406013Not applicable
• Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by SurgeryActive, not recruitingNCT03361436Phase 1
• Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal CancerTerminatedNCT03280277Early Phase 1
• Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck CancerWithdrawnNCT03261180Not applicable
• Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain TumorsWithdrawnNCT03234309Phase 2
• Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation TherapyCompletedNCT03135782Not applicable
• Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese LatinasCompletedNCT03028935Not applicable
• Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryCompletedNCT03009201Phase 1
• Assessing Community Cancer Care After Insurance ExpanSionSCompletedNCT02936609
• Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux DiseaseCompletedNCT02890979Not applicable
• Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation TherapyCompletedNCT02869412Not applicable
• Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal CancerWithdrawnNCT02857218Early Phase 1
• Pre-Prostatectomy Celecoxib or PlaceboTerminatedNCT02840162Phase 2
• Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
• Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple MyelomaCompletedNCT02504359Phase 1
• Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerCompletedNCT02503358Phase 1
• Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With GlioblastomaCompletedNCT02359097Not applicable
• CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersCompletedNCT02355262
• Contrast Enhanced MRI of the ProstateCompletedNCT02245282
• Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideCompletedNCT02228265
• DCE MRI in Patients With Pancreatic CancerTerminatedNCT02070705Not applicable
• Vascular Response to Brachytherapy Using Functional OCTCompletedNCT01955941
• Blood Vessel Patterns in Small Choroidal TumorsStatus unknownNCT01955915
• Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01913015Phase 1
• Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerCompletedNCT01780701
• CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer ScreeningCompletedNCT01773980
• Vietnamese Women's Health Project IIICompletedNCT01704235
• Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01689987Phase 1
• Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)CompletedNCT01635413Not applicable
• Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma DiagnosisCompletedNCT01556503
• Compassionate Use PonatinibNo longer availableNCT01549548
• MRI Assessment of Leukemia Response to TherapyCompletedNCT01537159
• Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)WithdrawnNCT01465815Phase 1/2

← OHSU Knight Cancer Institute overview and focus areas